Bio-Rad Laboratories Retained Earnings (Accumulated Deficit) 2010-2024 | BIO.B
Bio-Rad Laboratories retained earnings (accumulated deficit) for the quarter ending June 30, 2024 were $7.479B, a 15.06% decline year-over-year.
- Bio-Rad Laboratories retained earnings (accumulated deficit) for 2023 were $9.261B, a 6.44% decline from 2022.
- Bio-Rad Laboratories retained earnings (accumulated deficit) for 2022 were $9.898B, a 26.82% decline from 2021.
- Bio-Rad Laboratories retained earnings (accumulated deficit) for 2021 were $13.525B, a 45.94% increase from 2020.